Related Experiment Video
Updated: Jun 9, 2025
10:50
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
12.3K
[Dual pathway inhibition in peripheral arterial disease]
Vito Altamura1, Gian Francesco Mureddu2, Roberto Ceravolo3
1U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma.
Giornale Italiano Di Cardiologia (2006)
|October 25, 2024
Summary
Peripheral artery disease (PAD), once overlooked, now receives attention due to new treatments. Dual pathway inhibition, combining low-dose rivaroxaban and aspirin, offers new hope for PAD patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Peripheral artery disease (PAD) is globally prevalent but historically under-researched by cardiac specialists.
- PAD carries significant negative prognostic implications.
- Recent therapeutic advancements have stimulated renewed interest in PAD management.
Purpose of the Study:
- To review the underlying pathophysiology of peripheral artery disease.
- To trace the evolution of clinical trials informing current PAD treatment strategies.
- To highlight the impact of novel therapeutic approaches on PAD management.
Main Methods:
- This review synthesizes evidence from pivotal clinical trials, including COMPASS and VOYAGER PAD.
- It examines the pathophysiological mechanisms contributing to PAD.
- The review discusses the development and application of dual pathway inhibition strategies.
Main Results:
- Dual pathway inhibition, specifically low-dose rivaroxaban with acetylsalicylic acid, has demonstrated clear efficacy.
- These findings have revitalized therapeutic options for symptomatic PAD.
- The evidence supports improved outcomes for patients with PAD, including those with concomitant coronary artery disease.
Conclusions:
- New therapeutic strategies, particularly dual pathway inhibition, have significantly advanced PAD treatment.
- Understanding PAD pathophysiology and trial outcomes is crucial for effective clinical practice.
- The cardiac scientific community's engagement with PAD has been reignited, promising better patient care.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
2
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
2
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
2
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
2
01:27Peripheral Artery Disease III: Interprofessional Care
2
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
2
01:26Peripheral Artery Disease IV: Nursing Management
2
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
2
01:27Atherosclerosis II: Clinical manifestations and prevention
1
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
1
01:23Peripheral Artery Disease V: Postoperative Nursing Management
3
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
3